Journal article
Letter: mesalazine—a safe drug with rare serious adverse events? Authors’ reply
Abstract
LINKED CONTENT This article is linked to Sehgal et al and Scrivo et al papers. To view these articles, visit https://doi.org/10.1111/apt.14688 and https://doi.org/10.1111/apt.15691 .
Authors
Sehgal P; Narula N
Journal
Alimentary Pharmacology & Therapeutics, Vol. 51, No. 11, pp. 1212–1212
Publisher
Wiley
Publication Date
6 2020
DOI
10.1111/apt.15748
ISSN
0269-2813